Akums Drugs and Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

AKUMS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-1.3%1-day move

₹496.65

prior close

₹496.30

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-1.3-1.5-2.2-1.3-1.3+1.5-0.9+3.7+5.6+10.5+7.3+11.3+9.3+25.7

Up moveDown movePending

AI summary

Akums Drugs and Pharmaceuticals has filed a routine regulatory compliance certificate for the quarter ending March 31, 2026. The company's Registrar & Share Transfer Agent, MUFG Intime India Private Limited, has confirmed that all securities received from depository participants for dematerialisation during the quarter were properly processed, confirmed to the depositories, and the securities certificates were mutilated and cancelled within prescribed timelines. The depositories' names have been updated in the register of members as the registered owners. This is standard quarterly compliance documentation required under SEBI regulations for all listed companies.

Likely market impact

Neutral for shareholders - this is routine regulatory paperwork confirming proper handling of share dematerialisation requests. No implications for company financials, operations, or stock performance.